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Abstract 
An immunosensor for the sensitive detection and estimation of tumor necrosis factor-alpha 
(TNF-α) in undiluted serum has been developed via an electrochemical enzyme-linked 
immunosorbent assay (ELISA) process. Electrochemical sensing was performed using a TNF-α 
specific monoclonal antibody modified self-assembled monolayer of dithiobis(succinimidyl 
propionate) on a comb-shaped gold electrode microarray. After anti-TNF-α antibody binding, 
unreacted active groups of DTSP were blocked using ethanol amine (EA) and nonspecific binding 
was prevented using phosphate buffer based starting block T20 (SB). Sensitive and disposable SB–
EA–anti-TNF-α/DTSP/Au electrodes were exposed to solutions with different TNF-α 
concentrations for 20 min in undiluted serum. Conversion of 4-aminophenyl phosphate to 4-
aminophenol and its electrochemical oxidation was utilized for indirect estimation of TNF-α. 
Results for SB–anti-TNF-α/DTSP/Au electrodes indicate that the sensors can be used for the 
sensitive estimation of TNF-α in undiluted serum in the range 500 pg/ml to 100 ng/ml with a 
detection limit of 60 pg/ml and sensitivity of 0.46 (ng/ml)−1. Negligible interference from serum and 
other biomarker proteins was observed. The described electrochemical ELISA is much faster than 
conventional ELISA and can be applied for sensing of a range of analytes in real patient samples. 
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1. Introduction 
With an ever increasing demand for improved healthcare, informative biomolecules known 
as biomarkers are gaining much attention for accurate and faster diagnosis and prognosis of a 
specific disease.[1, 2] These can be found at the early stage of diseases and quantification of these 
biomarkers from blood, urine or other tissues can provide vital information regarding patient 
health.[3] Thus, detection and estimation of their level accurately and sensitively is critical for early 
stage identification and proper recovery. Several approaches and protocols for their detection, such 
as optical (fluorescence, chemiluminescence, UV-visible), biophotonic, electrochemical sensors, 
electro-chemiluminescence, etc. have been reported in literature.[3-5] Among these, optical 
methods such as ELISA, fluorescence and bio-photonic have provided high quality data and are 
most often been employed for detection. However, such optical methods require complex 
equipment and trained personnel for operation; thus the development of alternative methods that 
give high quality data with simple procedures is desired.[4, 6] Owing to their accuracy, higher 
sensitivity, portability, low cost and simplicity, electrochemical immunosensors have recently 
gained significant attention.[1, 3, 4, 7, 8] Among electrochemical immunosensors, electrochemical 
ELISA, which uses the selectivity of an antigen–antibody interaction on an electrochemical 
platform, is seen as one of the most promising methods. Electrochemical ELISA has the added 
advantage of not being affected by particles, chromophores, and fluorophores that might be present 
in a sample and which might cause interference with optical detection.[9-11] However, a simpler 
method for developing a convenient, stable and sensitive electrochemical ELISA still requires 
significant research. 
In the development of an immunosensor, the immobilization of a capturing molecule, such 
as an antibody, onto a surface is crucial and can determine the stability of the sensor.[10-14] In 
attempts to immobilize and stabilize capturing biomolecules, a number of approaches such as the 
use of direct physical adsorption, self-assembled monolayers (SAM), polymer membranes, etc. 
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have been investigated.[1, 10, 11, 15] Among the covalent immobilization methods, use of thiol 
SAMs has shown a number of advantages such as an easy and efficient immobilization with 
uniform surface coverage. However, most of the SAMs require either activation or further 
modification before immobilization of the bioreceptor, which might disturb the integrity of the 
biomolecule.[16] Recently, SAMs based on dithiobissuccinimidyl propionate (DTSP) have shown 
that they can be used for facile covalent binding of biomolecules under very mild conditions, thus 
preserving their activity.[17-19] For successful development, a desirable biosensor should have 
capability to identify the desired biomarker in an unbiased manner in complex samples (e.g. serum) 
with various potentially interfering materials. Eliminating serum background is critical for 
biosensor development as serum contains high levels of cells, proteins, electrolytes, lipids, etc. 
which may interfere with the detection signal and may give rise to false positive signals in real 
samples.[4] For point-of-care (POC) applications, where both sample collection and the test are 
done on site, the use of blood or serum as a sample is unavoidable. Researchers have described 
various methods to reduce the serum background interference.[4, 20, 21] Among these, the use of 
serum dilution before testing has proven to be quite an effective method; however it also causes 
dilution of the target protein, thus lowering its accurate detection.  
In the present work, an electrochemical ELISA based system has been developed by solving 
various issues involved in their development. DTSP has been used to immobilize antibody on 
comb-shaped gold micro array electrodes. A phosphate buffer saline / tween20 based starting 
blocker (SB) has been utilized for preventing false signals from detection of target tumor necrosis 
factor-alpha (TNF-α) protein in undiluted serum. SB contains a proprietary protein that provides 
exceptional performance and broad compatibility with ELISA assays. Furthermore, alkaline 
phosphatase that can biocatalyze 4-aminophenyl phosphate (4-APP), resulting in enhanced redox 
signal by enriching the catalysed product on the working electrode during sandwich assay, has been 
employed to get higher response. During the immunoassay, increasing TNF-α concentration causes 
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increased antigen binding with immobilized antibodies on the sensor surface, which upon 
interaction with a second antibody and ALP-streptavidin results in higher conversion of 4-APP to 4-
amino phenol. On electrochemical oxidation, this releases two electrons to produce quinonimide 
and is therefore detected on the surface. Figure 1b shows the schematic steps of the immunoassay 
and detection process. The chosen TNF-α protein is a cytokine serving as potent protein biomarker 
for various physiological and pathological processes such as apoptotic cell death, fever and 
cachexia. It is also known to be involved in immune system regulation and in systemic 
inflammation.[3] In healthy individuals, cytokine levels, like TNF-α, usually exist from pg/ml to 
ng/ml levels, however in pathological conditions such as rheumatoid arthritis (RA), its level rises by 
ten to hundred times causing local cell apoptosis, thus necessitating rapid detection method for early 
disease diagnosis and prognosis. Its elevated levels to ng/ml in serum has also shown to be 
associated with a wide range of diseases, such as systemic erythema nodosum leprosum, Crohn’s 
disease, endotoxic shock, HIV infection, stroke, neonatal listeriosis, severe meningococcemia and 
osteosarcoma [1, 3, 7, 15, 18, 22, 23], thus making it an important biomarker necessitating the 
development of immunosensors for its sensitive and selective detection. Current methods of 
detecting TNF-α include optical enzyme-linked immunosorbent assay (ELISA) along with 
chemiluminescence, radio-immunoassays, mass spectrometry/laser desorption, flow cytometry, 
enzyme-linked immunosorbent spot assay, and immuno-PCR.[3-5, 15, 24] Among these 
commercially available products, ELISA is quite sensitive and mainly employed; however it suffers 
from relatively high background signal and long procedure, bulky instrumentation and requirement 
of trained personnel. Other methods are also expensive, laborious and suffer from similar problems. 
In the present work attempt, a self-assembled monolayer based electrochemical ELISA for protein 
biomarker detection in undiluted serum has been developed. 
 
2. Materials and Methods 
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2.1 Reagents 
TNF-, primary antibody and biotin-conjugated secondary antibody were procured from 
Biolegend (USA); streptavidin-conjugated alkaline phosphate (ALP) solution from Affymetrix UK 
Ltd; 4-aminophenyl phosphate monosodium salt (4-APP) from Santa Cruz Biotechnology (USA); 
starting block PBST20, starting block TBST20 and dithiobis (succinimidyl propionate) (DTSP) 
from Fisher Scientific (UK); FemtoTBS from Gbioscience (UK); sodium borohydride and dimethyl 
sulfoxide (DMSO) from Sigma (UK). All other chemicals were of analytical grade and were used 
without further purification.  
 
2.2 Gold electrode fabrication 
Comb-shaped gold micro-electrode arrays were created using lithographic and micro-
fabrication techniques on silicon wafers with a thick layer of thermally grown oxide layer as 
described in an earlier report.[18] Comb fingers of 5 μm thickness and 3200 μm length, spaced at 
25 μm were created over the length of 5500 μm. Counter and pseudo reference electrodes of gold 
around the working comb shape electrode were deposited on the chip in the same manner. The 
fabricated electrodes were pre-cleaned with isopropyl alcohol, acetone and with copious amounts of 
de-ionized milli-Q water (Millipore, UK) followed by treating for 30 min using UV-ozone 
(ProCleaner, BioForce Nanosciences, USA) before use.  
 
2.3 DTSP SAM formation and immobilization of anti-TNF-α antibodies  
For DTSP SAM formation, 1 ml of 2 mg/ml solution of DTSP in DMSO was prepared and 
reduced with 5 l of sodium borohydride (10 mg/ml in H2O) for 10 min at room temperature. Each 
gold electrode was then incubated for 1 h with 100 l of DTSP solution at room temperature (~22 
C). After SAM formation, unbound DTSP molecules were removed by washing the electrodes 
with DMSO, acetone and milli-Q water, followed by air blow drying. A solution chamber covering 
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the SAM-modified electrodes was created by fixing a laser cut double-sided tape (Figure 1). To 
make the chamber, liner on one side of tape was pealed and pasted on electrode making a very thin 
chamber, capable of holding 50 µl solution covering the entire chamber. Figure 1 shows the picture 
of the sensor chip with and without double-sided tape chamber along with a schematic of the SB–
ethanol amine–anti-TNF-α/DTSP/Au fabrication. The DTSP modified electrodes were then 
incubated with 10 g/ml TNF-α antibody solution in PBS for 90 min at 37 C. During incubation, 
antibodies were covalently attached to the DTSP surface via nucleophilic attack of amino groups of 
antibodies to reactive succinimidyl groups on DTSP. The prepared anti-TNF-α/DSP/Au electrode 
was washed thoroughly with PBS followed by incubation with 1% ethanol amine (EA) in PBS for 
10 min and again washed with PBS to block any remaining active groups of DTSP. Electrodes were 
then incubated with starting block PBST20 (SB) for 30 min to block empty places on the electrode 
surface and to prevent any non-specific adsorption. The prepared electrodes were stored at 4 C 
when not in use and were characterized using optical and electrochemical techniques during 
experimentation.  
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Figure 1. (a) Schematic of the SB–EA–anti-TNF-α/DTSP/Au fabrication. (b) Schematic for 
immunoassay and testing. 
 
2.4 Immunoassay process sequence 
The electrochemical immunoassay started with incubation of the sensor chip with 50 µl of 
the desired concentration of TNF-α in undiluted serum, where anti-TNF-α antibodies bound on 
sensor surface capture TNF-α in the sample. On completion of optimized 20 min of incubation, the 
sensor chip was rinsed thoroughly using 1x Femto TBST washing buffer. After the antigen binding 
step, 50 µl of 10 µg/ml secondary anti-TNF-α with biotin tag solution in starting block TBST20 was 
poured on the sensor and incubated for another 20 min followed by thorough washing with 1x 
Femto TBST. The secondary anti-TNF-α modified sensor was then allowed to interact for 20 min 
with streptavidin-alkaline phosphatase solution in starting block TBST20 (50 µl of 10 µg/ml) 
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followed by washing again with 1x Femto TBST. In a final incubation, the sensor chip was 
incubated with 50 µl of 2 mg/ml 4-APP in deoxygenated tris-HCl buffer (100 mM, pH 9) 
containing 4 mg/ml MgCl2·6H2O for 20 min followed by differential pulse voltammetric (DPV) 
signal recording. To record the DPV signal, conditions were initially taken from Bettazi et al. [23]; 
however to avoid oxygen interference and to record optimum oxidation signal of 4-amino phenol to 
quinonimide at around 0.2 V, a potential range of -0.2 to 0.4 V was selected. Also, the optimum 
response was observed when an amplitude of 25 mV, step potential of 10 mV, and interval time of 
0.1 s were used, which were thus utilized in the present study. DPV measurement was recorded 
using an µAutolab III / FRA2 potentiostat/galvanostat (Metrohm Autolab, Netherlands) controlled 
by General Purpose Electrochemical System (GPES) version 4.9 software. Undiluted serum was 
used as a control to monitor the effect of serum proteins on the measurement. All experiments for 
TNF-α detection were carried out at least in triplicate using separate electrodes and the standard 
deviations were represented via error bars. Figure 1b shows the schematic of immunoassay and 
testing. 
 
3. Results and discussions 
3.1 Chip fabrication and characterization. 
Figure 2 shows the optical image of the prepared chip and its characterization using cyclic 
voltammetry and electrochemical impedance spectroscopy in 10 mM PBS pH 7.4 containing 5 mM 
FeCN6
3-/4- . It is clear form Figure 2a that the prepared chip exhibits sharp oxidation and reduction 
peaks with equal current of around 155 µA. Optical image in the inset shows the reference, counter 
and two working comb shaped micro electrodes array arranged in an interdigitated manner. Figure 
2b shows a Nyquist plot for the cleaned blank chip in a three-electrodes configuration; good 
conductivity with low charge transfer resistance of around 141  is observed. The slight variation 
in the diffusion curve for Warburg impedance region may be attributed to the effect caused by 
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exposed titanium layer under each gold comb finger. Results thus indicate the preparation of gold 
sensor chips. Also, chips prepared in batch showed almost the same response, with variations of less 
than 1%.  
 
Figure 2 (a) Cyclic voltammetric and (b) electrochemical impedance scan for clean blank chip in 10 
mM PBS pH 7.4 containing 5 mM FeCN6
3-/4- . Inset in (a) shows the optical image of the prepared 
chip. 
 
3.2 Atomic force microscopic imaging and contact angle measurements 
Figure 3a-b shows atomic force microscopic (AFM) images of blank gold and EA-anti-
TNF-α/DTSP/Au taken in tapping mode using a 10 nm AFM tip. The observed change of granular 
morphology for the blank gold surface (Figure 3a) to smoother and globular morphology for anti-
TNF-α/DTSP/Au (Figure 3b) suggests the successful immobilization of anti-TNF-α onto the gold 
surface. Furthermore, contact angle measurements were carried out for the blank Au surface (Figure 
3c), DTSP/Au (Figure 3d) and EA–anti-TNF-α/DTSP/Au (Figure 3e) to characterize anti-TNF-α 
immobilization. Contact angle measurements were performed using an in-house built optical angle 
measurement system. The electrodes were placed on the stage and a 10 µl drop of water was 
dispensed on the electrode with the dispensing system. The wetting of surface was then captured 
using a Nikon p520 camera and contact angle was measured using an on-screen protractor. In 
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Figure 3c-e increase in contact angle from 25˚ for the blank gold surface to 51˚ for DTSP/Au 
indicate the successful SAM formation. A decrease in contact angle value to 42˚ after anti-TNF-α 
binding confirm the immobilization of antibody; decrease in contact angle after anti-TNF-α binding 
might be attributed to the hydrophilic nature of antibody. 
 
Figure 3 AFM images for (a) blank cleaned gold surface, (b) after anti-TNF-α binding and contact 
angle images for (c) blank cleaned gold surface, (d) after DTSP SAM formation and (e) after anti-
TNF-α binding. 
 
3.3 SB–EA–anti-TNF-α/DTSP/Au electrode and its working principle 
Figure 4 shows the cyclic voltammetric scans and impedance spectra at every step of the 
immunosensor electrode modification as indicated in the schematic of Figure 1. In an 
immunosensor electrode fabrication, DTSP provides the matrix layer on gold and acts as a linker for 
covalent antibody binding under mild conditions. As seen in Figure 4a, the peak current decreases 
from 155 µA for the blank electrode to 105 µA after DTSP SAM formation, suggesting its layer 
(a) (b)
(c) (d) (e)
11 
 
formation on the gold surface. This is further confirmed by the increase in charge transfer resistance 
(Rct) from 141 for the blank chip to 5.18 k after DTSP SAM formation. After binding of anti-
TNF-α, a further decrease in peak current to 55 µA and increase in Rct to 11.90 k suggest 
successful binding of antibodies on the surface of the DTSP modified gold electrode. A decrease in 
Rct to 7.04 k and increase in peak current to 70 µA after EA treatment, indicate the removal of 
physically adsorbed antibodies on the surface. Finally, after blocking with starting block PBST20, 
the decrease in peak current to 29 µA and increase in Rct to 13.70 k suggest successful blocking of 
free spaces on the sensor surface. Decrease in peak current and increase in Rct after antibody 
binding and blocking may be attributed to the insulating nature of proteins, which hinder the charge 
transfer from the solution to the surface of the electrode. 
 
Figure 4. Cyclic voltammetric scans (a) and impedance spectra (b) at every step of the 
immunosensor electrode modification. 
 
The electroactive surface area of Au, DTSP/Au and EA–Ab/DTSP/Au electrode was 
estimated via scan rate studies in 5.0 mM Fe(CN)6
4-/3- with 1 M KCl at different scan rates from 30 
to 100 mV/s (see Supplementary Information, Figure S-1 a-c). Oxidation peak current data was then 
plotted against the square root of the scan rate and the slope was utilized to estimate electroactive 
surface area using the Randles-Sevcik equation: Ip = 2.69×10
5 A D1/2 n3/2 υ1/2 c,. where Ip is the peak 
current (A), n is the number of exchanged electrons (1 for Fe(CN)6
4-/3-), c is the concentration of the 
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electroactive specie (mol/cm3), A is the electroactive area (cm2), D is the diffusion coefficient 
(cm2/s) and υ is the scan rate (V/s). In the studied scan rate range, the oxidation peak currents for 
Au, DTSP/Au and EA–Ab/DTSP/Au electrodes (see Supplementary Information, Figure S-1 d-f) 
were found to be linearly dependent on the square root of the scan rate. Using the D value of 0.718 
x 10-5 cm2/s for 5 mM FeCN6
3-/4- in 1 M KCl [25], the active surface area was estimated to be 19.38 
mm2, 23.02 mm2 and 21.94 mm2 for Au, DTSP/Au, and EA–Ab/DTSP/Au, respectively. 
Observance of such high area might be attributed to radial diffusion occurring on the micro-
electrode bands in comb-shaped gold micro-electrode arrays.[26]  
 
3.4 TNF-α response studies  
TNF-α interaction with surface bound antibodies was studied at both room temperature and 
37 C for different incubation times. It was observed that with increasing incubation temperature to 
37 C, the peak current response observed for p-phenol amine oxidation at desired TNF-α 
concentrations increases; however, the peak current response observed for p-phenol amine 
oxidation for serum only sample (background signal) is also found to be higher and, thus, not much 
enhancement in normalized signal (peak current for desired TNF-α concentrations / peak current for 
serum only) was observed. Similarly, the peak current signal was found to be increasing with 
increasing incubation time; however, good signal sensitivity was observed at 20 min and no further 
normalized enhancement was observed for 30 min incubation. Thus, 20 min of incubation time at 
room temperature (22 C) was selected for further experiments.  
Figure 5 (a) shows the DPV spectra for different concentrations (500 pg/ml – 100 ng/ml) of 
TNF-α in undiluted serum. The peak current for the immunosensor chips was found to be around 
0.145 µA when tested for serum only and increased from around 0.185 µA for 500 pg/ml TNF-α in 
undiluted serum to around 6.875 µA for 100 ng/ml TNF-α in undiluted serum. It is clear from the 
data that with increasing TNF-α concentration in undiluted serum the peak current response 
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observed for p-phenol amine oxidation increases and the sensor can be used in the tested 
concentration range. Furthermore, the increasing peak current indicates successful binding of 
antigens and secondary tags, which resulted in increasing production of the final electroactive 
product during alkaline phosphatase based catalytic conversion of 4-amino phenyl phosphate to 4-
amino phenol, thus producing higher currents for higher concentrations. Figure 5 (b), which shows 
the spectra at concentrations equal or lower than 5 ng/ml, clearly reveals that the signal for serum is 
negligible and a good signal is observed even for 500 pg/ml of TNF-α and can easily be 
differentiated from the background signal of the serum only sample. It is noted that in DPV curves 
oxidation signal of 4-amino phenol was found to be with a shoulder. To understand the reason for 
shoulder peak, additional experiments were carried out, where the assay was performed on one chip 
and tested on blank chip and no such shoulder peak was observed (Supplementary Information, 
Figure S-2a). However, when the assay was carried out on a surface kept separately on the sensor 
chip, the 2nd peak at a slightly higher potential was observed (Supplementary Information, Figure S-
2b).[27] The exact reason for the shoulder peak is still not clear, however we expect that it arises 
from the adsorbed molecules on the sensor surface. When biomolecules are covalently attached to 
the surface, the 2nd peaks moves closer to the peak for p-phenol amine oxidation and the 
overlapping of the peaks gives rose to a shoulder. Further detailed investigations are currently under 
investigation.  
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Figure 5. DPV curves for different concentrations: (a) 500 pg/ml to 100 ng/ml; (b) 500 pg/ml to 5 
ng/ml of TNF-α in undiluted serum. 
 
Figure 6a shows the normalized peak current at various concentrations of TNF-α. 
Normalization was done by dividing the peak current for the desired concentration by the peak 
current observed for serum only. This normalization was done to better show the dose response, as 
there is a small day to day and batch to batch variation (less than 4%, as indicated by the error bars). 
It is clear from the dose response that the biosensor chips show linearity for TNF-α sensing in the 
concentration range 500 pg/ml – 100 ng/ml, which could be characterized using the linear equation: 
Ic/Ic0 = 0.987 + 0.46 cTNF-α (ng/ml). The SB–EA–anti-TNF-α/DTSP/Au electrode exhibits a 
sensitivity of 0.46 (ng/ml)−1 and standard deviation of 0.0092. Detection limit was estimated using 
3× standard deviation / sensitivity and found to be 60 pg/ml. Thus, it is clear from the results that 
the SB–EA–anti-TNF-α/DTSP/Au electrode can be used successfully for testing TNF-α in 
undiluted serum and can be utilized for developing sensitive biosensors for other proteins as well.  
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Figure 6. (a) Normalized peak current at various concentrations of TNF-α and (b) normalized peak 
current for 1 ng ml-1 of TNF-α using SB–EA–anti-TNF-α/DTSP/Au electrodes at various intervals 
 
3.5 Shelf life and selectivity studies 
To estimate storage life, DPV studies were performed to test the shelf life of the SB–EA–
anti-TNF-α/DTSP/Au electrodes over a 5-week period, at intervals of one week. 1 ng/ml of TNF-α 
in serum was tested every week on selected electrodes from a set made at the same time and stored 
at 4 C when not in use. Figure 6b shows that the SB–EA–anti-TNF-α/DTSP/Au electrodes retain 
more than 93% of the initial signal even after five weeks, indicating good stability of the biolayer. 
Also, SB–EA–anti-TNF-α/DTSP/Au electrodes were studied for selectivity studies against other 
protein markers such as prostate specific antigen (PSA), human epidermal growth factor receptors 2 
and 4 (HER2 and HER4) at high concentrations of 100 ng/ml. DPV results of interference study 
from undiluted serum, 100 ng/ml of PSA in serum, 100 ng/ml of HER 2 in serum and 100 ng/ml of 
HER 4 in serum did not show significant response to any other protein in serum even at such high 
concentrations (see Supplementary Information Figure S-3). Thus, the SB–EA–Anti-TNF-
α/DTSP/Au electrode offers a new platform for biosensor development to selectively detect protein 
biomarkers in undiluted serum with high sensitivity. Table 1 compares the results of the present 
study with other reported results for TNF-α, clearly suggesting that the SB–EA–anti-TNF-
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α/DTSP/Au electrode can be used to get better response in a dynamic wide range in undiluted 
serum samples. 
 
Table 1: Characteristics of the SB–EA–anti-TNF-α/DTSP/Au electrode and those reported in 
literature. 
Immobilization 
Matrix 
Sensing 
element 
Sample 
medium 
Sample 
incubation 
time 
Detection 
method 
Linearity Detection 
limit 
Ref. 
Gold MB tagged 
thiolated TNF-α 
aptamer 
blood 15 min SWV 10 - 100 ng/ 
ml 
10 ng/ml [15] 
DNA 
nanostructure-
decorated gold 
surfaces 
Anti-TNF- α 
antibody 
1% BSA 
in PBS 
60 min Ampero-
metry 
0.1 - 2.5 ng/ 
ml 
0.1 ng/ml [28] 
MUA SAM Anti-TNF- α 
antibody 
Buffer 15 min QCM 40 – 2000 
ng/ml 
25 ng/ml [29] 
Avidin-modified 
SPE 
Anti-TNF- α 
antibody 
Buffer 45 min SWV 0.1 – 1000 
ng/ml 
0.05 
ng/ml 
[22] 
Gold MB tagged 
thiolated TNF-α 
aptamer 
Cell 
culture 
medium 
30 min SWV 9 – 88 ng/ml 5.46 
ng/ml 
[30] 
DTSP SAM Anti-TNF-α 
antibody 
Serum 20 min DPV 0.5 – 100 
ng/ml 
0.06 
ng/ml 
this 
work 
SWV: square wave voltammetry; MUA: mercaptoundecanoic acid; SPE: Screen printed electrode; 
MB: Methylene blue 
 
4. Conclusion 
In conclusion, SB–EA–anti-TNF-α/DTSP/Au electrodes were developed using DTSP SAM 
as a matrix and immobilizing agent for antibodies. The biosensor shows good selective 
measurement of TNF-α in undiluted serum in the concentration range of 500 pg/ml – 100 ng/ml, 
with very low non-specific response to serum proteins. The prepared electrodes showed sensitivity 
of 0.46 (ng/ml)−1 and a low detection limit of 60 pg/ml. Furthermore, the fabrication method was 
found be simple and the prepared electrodes found to be stable over a 5 weeks’ period when stored 
at 4 C in a humid chamber. The studies show that the developed platform is very robust and can be 
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employed for the detection of other proteins and biomolecules in undiluted serum, paving the way 
to a range of novel low cost and rapid blood biosensors. 
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